Burlingame, CA, April 21, 2025 (GLOBE NEWSWIRE) -- Coherent Market Insights published a report, titled, the global meningococcal vaccines market size is estimated to grow from US$ 4.53 Billion in ...

The ACIP voted that Penmenvy may be used as part of the adolescent meningococcal vaccination schedule as an alternative to separate administration of MenACWY and MenB. The Centers for Disease ...

The recommendation is an alternative to administering meningococcal serogroups A, C, W and Y (MenACWY) and meningococcal serogroup B (MenB) vaccines separately during the same visit, usually at ...

Burlingame, CA, April 21, 2025 (GLOBE NEWSWIRE) -- Coherent Market Insights published a report, titled, the global meningococcal vaccines market size is estimated to grow from US$ 4.53 Billion in 2025 ...

Hong Kong has recorded a surge in cases of a life-threatening bacterial infection in the first four months of this year, prompting a leading infectious disease expert to call on the public to ...

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in ...

GSK’s five-in-one meningococcal vaccine has been recommended by the US Centers for Disease Control and Prevention’s (CDC) immunisation panel as part of the adolescent meningococcal vaccination ...

ACIP voted to recommend that persons over 10 years old receive a single dose of PENMENVY as an alternative to separate administration of meningococcal serogroups A, C, W, and Y (MenACWY ...

The Committee voted to recommend that persons over 10 years old receive a single dose of Penmenvy as an alternative to separate administration of meningococcal serogroups A, C, W and Y (MenACWY ...

GSK plc announced that the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has voted to recommend use of Penmenvy (Meningococcal Groups A, B, ...